Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...
NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...
The 2020 Nobel Prize in Chemistry was awarded for the development of CRISPR/Cas9, a method also known as "gene scissors," ...
Key growth drivers in the genome editing market include rising cancer/genetic disorder cases, increased investments, and supportive policies. North America leads in R&D, while Asia Pacific shows rapid ...
If DNA is just a string of letters, could AI learn to read it … or even write it? Bioengineering researcher Eric Nguyen ...
Cheyenne locals Georgia and Dave Rowswell, the owners of Open Door Arts (formerly Blue Door Arts), leave next week for an ...
The commercial success of existing lipid-lowering medications highlights the enormous market potential for effective ...
While biotech hubs like Boston, San Francisco, San Diego and Raleigh-Durham, North Carolina, are home to thousands of ...
Horses with genomic edits to make them run faster have been banned from polo, but a zoo of CRISPR-edited animals is gaining ...
A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification. (Nanowerk Spotlight) Hidden ...
Crispr Therapeutics is synonymous with Cathie Wood and now ranks at number 10 across ARK’s combined portfolio, worth an eye-catching $428.7 million, with a portfolio weighting of 3.29%. Her consistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback